In this episode, Larry Green, MD, interviews Seemal Desai, MD, about identifying and treating psoriasis in patients with skin of color, as well as what the field of dermatology can do to improve patient care and access for this patient population.

In this episode, Dr Larry Green interviews Dr George Han about current and future oral small molecules for psoriasis.

Psoriasis has a known association with inflammatory bowel disease, including Crohn disease and ulcerative colitis. Dermatologists should keep the association in mind when treating their patients with psoriasis.

In this podcast, Erin Boh, MD, PhD, reviews the latest updates in the safety of psoriasis therapies, including tumor necrosis factor inhibitors.

In this podcast, April Armstrong, MD, reviews the latest updates in oral therapies for the treatment of psoriasis, and discusses why having these options is important for patients.

In this episode, Larry Green, MD, describes the essential know-hows in diagnosing and treating nail psoriasis, including the importance of recognizing nail psoriasis as a hallmark of psoriatic arthritis.

In this episode, Larry Green, MD, interviews Mark Lebwohl, MD, about his career and role in pivotal topical therapy trials. Dr Lebwohl also shares his thoughts on how the field will evolve over the next 10 years.

Lawrence Green, MD, discusses with Kristi Hawley, DO, strategies for selecting treatment options for patients with obesity and psoriasis, as well as patients at risk for cardiometabolic disease.

Kristi Hawley, DO, reviews the link between diabetes, obesity, and psoriasis, as well as treatment considerations for this patient population.